Ace Blend, an Indian nutrition and supplements company, has raised $9.91m (about ₹95 crore, according to Inc42) in a Series A2 round led by 3one4 Capital. Existing investor Fireside Ventures also invested and increased its stake. The company announced the round on 29 October 2026.
Fireside Ventures led Ace Blend's previous round, a $3.3m pre-Series A. The valuation of the new round was not disclosed.
“We would be in this industry even if it were not a trending one.”Shivam Hingorani, Founder and Chief Vision Officer, Ace Blend
What Ace Blend does
Ace Blend makes plant-based protein powders, superfood mixes and supplements aimed at heart health, brain health, sleep, recovery, gut health, strength and immunity. Inc42 reported that it sells about 14 products through its own website, which brings in about half of its revenue, and through Amazon, Flipkart, Zepto and Blinkit.
The company handles sourcing, formulation and manufacturing itself. It says its products are clinically validated and batch-tested by accredited laboratories in Europe, that DSM and TCI have given it exclusive Indian rights to some of their technologies, and that more than 400 doctors recommend its products.
Ace Blend says revenue grew 300% in FY26 and that more than 46% of customers buy again. Inc42 put the repeat purchase rate at nearly 48%. The company did not disclose its revenue, but told Inc42 it is aiming for annual recurring revenue of ₹250–300 crore within the next 12 to 18 months.
Who is behind it
Shivam Hingorani founded Ace Blend and made its first sales in 2018 after about ten years of research, according to the company. Saif Mehkri, who has nearly three decades of experience in the nutrition industry, joined as co-founder in 2022.
Pranav Pai, managing partner of 3one4 Capital, said the category is crowded with brands that compete mainly on marketing and that his firm sees a chance to scale a durable Indian consumer-health company. Ankita Balotia, a principal at Fireside Ventures, pointed to customers' high repeat rates as the strongest validation of the brand.
3one4 Capital is an Indian venture firm whose portfolio includes Licious, Darwinbox and Kapiva. Fireside Ventures invests in consumer brands and has backed Ace Blend since its pre-Series A round.
What the money is for
Ace Blend will use the funding for research-led product development and to launch new nutrition formats, for which it says it holds issued patents. The first new format is due in the fourth quarter of FY27.
Inc42 reported that part of the money will pay for clinical trials run by contract research organisations, with results meant for peer-reviewed journals, as well as stronger sourcing and supply chain operations, automated batch testing and shelf-life studies. Products in development include a gut-health formula, a blend aimed at lowering inflammation, and an eye-health product.
Hingorani told Inc42 that trust alone is not enough in the supplements market. Inc42, citing Grand View Research, said India's dietary supplements market was worth $5.8bn in 2025.
Grand View Research expects the Indian market to reach $6.6bn in 2026 and $12.4bn by 2033, Inc42 reported.
Company website: aceblend.com